Market Overview

Earnings Season Is The Right Prescription For Health Care ETFs

Share:
Earnings Season Is The Right Prescription For Health Care ETFs
Related XLV
Fast Money Traders Share Their Safety Trades
Private Insurance Doesn't Mean Lower Out-Of-Pocket Costs
Top 10 Health Care Stocks: Which To Buy? Part 3 (Seeking Alpha)
Related SPY
Monday's Market Wrap: Stocks Record Modest Declines
The Pros And Cons Of Trading Options
Should Investors Care That Stocks Are Expensive? (Seeking Alpha)

The second quarter earnings season has generally been regarded as better than average, with 446 of the 500 companies within the S&P 500 Index having reported thus far. 

According to recent FactSet research data, 73 percent have reported earnings above mean estimates and, on average, companies are beating expectations by 4.2 percent. 

Related: Coal ETF Pursues New Uptrend

However, one sector in particular has bounded ahead of its peers, and related ETFs are cashing in. Health care companies have been one of the shining stars of the market this year and continue to show impressive relative strength.   

According to data compiled by Bloomberg, “Ninety percent of healthcare companies have exceeded analysts’ profit forecasts so far this reporting period, while 88 percent reported revenue that beat estimates.”

Confidence In Further Potential

That fundamental strength has been a catalyst for investors to pile into funds such as the Health Care Select Sector SPDR (NYSE: XLV). Through August 12, the ETF has garnered more than $1 billion in net inflows as a result of confidence in further profit potential.

This health care benchmark tracks 55 large-cap companies engaged in pharmaceuticals, biotechnology and medical services. The largest holdings in the Health Care Select Sector SPDR include Johnson & Johnson (NYSE: JNJ) and Pfizer Inc (NYSE: PFE), which together control more than 20 percent of the assets in this market-cap weighted fund. 

The Health Care Select Sector SPDR is the dominant ETF in the healthcare sector with more than $10 billion in total assets, and it charges an expense ratio of 0.16 percent annually.

So far this year, the ETF has gained 9.77 percent, compared to the 5.61 percent total return of the SPDR S&P 500 ETF (NYSE: SPY). 

xlv_spy.png

This outperformance may be another reason asset flows have continued to chase into the health care sector.  So far this year, the Health Care Select Sector SPDR is trailing only the Energy Select Sector SPDR (NYSE: XLE) $2.6 billion net inflows in large-cap sector offerings.

The next test for health care will be whether summer volatility will continue to weigh on stocks or if this mini-correction has run its course. A resumption of the uptrend may provide further confirmation for the health care theme.

Posted-In: Sector ETFs Health Care Trading Ideas ETFs General Best of Benzinga

 

Related Articles (JNJ + PFE)

View Comments and Join the Discussion!